|
|
 |

[08/25/2004]
Diagnostic tools |
 |
 It is the examination of a blood sample by
optical microscopy which provides direct parasitologic diagnosis.
The serologic tests simply indicate a contact with the parasite and
are only of epidemiologic interest. A new generation of tests is
being developed, made possible by the isolation and the
purification of antigens in various stages of the parasitic
development and by the production of specific monoclonal antibodies
of these antigens with very high level avidity.
|  |
Microscopic diagnosis
| Highlighting parasitic antigens
Detection of HRP2 - Other tests are under preparation, some in the assessment
phase. The target may be the detection of plasmodium LDH. The
multi-species tests are for the future.
- The highlighting of the parasitic antigens in the infected
erythrocytes, solubilized then revealed by radio-immunotitration or
by immunoenzymatic techniques (ELISA), have been described. They
remain poorly adapted for routine diagnosis due to the difficulty
to standardize the reagents used and to eliminate all the
antimalarial antibodies from the sample tested.
| Techniques making use of molecular biology
These techniques are based on the detection of sequences
characteristic of plasmodium genomic DNA by means of catheters of
denatured DNA containing a complementary nucleotidic sequence of a
repetitive sequence of the parasitic DNA. The PCR (polymerase chain
reaction) improves the hybridation techniques by selectively
amplifying a region of the genome of the parasite. But these
techniques are still in the domain of the research laboratory and
are not adapted to the emergency.
| Continuous flow cytometry
This technique uses a flow cytometer, a sophisticated and costly
device, which limits its use to a few well-equipped laboratories
with highly qualified staff.
It has been proven capable of revealing automatically the parasite
infected red blood cells after marking the parasitic DNA with
thiazol orange. This is a very sensitive technique, providing
quantification of the parasitemia, and specific but not providing a
differentiation of the species.
| Main characteristics of current diagnostic means
The blood smear
test: - Detection threshold: 100 HPM (infected RBCs per microliter),
i.e. 0.0025 %, i.e. 1 parasite for 200 fields.
- Advantages: the smear test provides a diagnosis of species, a
study of the plasmodium density and that of the associated
hematological signs. It is suitable for emergency use. It also
provides diagnosis of other pathogenic sanguicolous agents.
Finally, it enables a deferred reading in time and space, and thus
a control to be made.
- Drawbacks: it requires a good technical performance, the
reading is long (20 minutes), the threshold of detection is high
and training is indispensable.
The QBC Malaria
Test®: - Detection threshold: 1 HPM.
- Advantages: the detection threshold is low, the test is adapted
to emergency use, the diagnosis of other pathogenic sanguicolous
agents is possible, the training is simple for staff familiar with
the reading of the blood smear test.
- Drawbacks: the equipment is expensive, the test does not
provide a species diagnosis, a study of the plasmodium density nor
that of the associated hematological signs; the training requires a
prior learning of the reading of a blood smear test; the deferred
reading in time is limited to five days.
Detection of HRP2: - Detection threshold: estimated at 10 HPM. In practice,
detection of HRP2 is always positive if the parasitic density is
0.01 %.
- Advantages: the technique provides a diagnosis of the infection
by Plasmodium falciparum. It is
adapted to emergency and to use in the field. Its apprenticeship is
simple. HRP2 clearance being longer than the parasitic clearance,
the technique provides a retrospective diagnosis of infection
by Plasmodium falciparum. Finally,
it enables a deferred reading in time and space..
- Drawbacks: the technique is strictly specific
to Plasmodium falciparum. It does
not help in the diagnosis of other sanguicolous pathogenic agents,
the study of the plasmodium density nor that of associated
hematological signs.
|
 |
|
 |